Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

A statistical model for identifying proteins by tandem mass spectrometry.

Nesvizhskii, A., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,902 · see citing works

A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics

Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,486 · see citing works

Direct analysis of protein complexes using mass spectrometry

Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218 · see citing works

Identifying biological themes within lists of genes with EASE

Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950 · see citing works

Deaths: preliminary data for 2003.

Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649 · see citing works

Effect of Statin Therapy on C-Reactive Protein Levels

Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,642 · see citing works

High-Density Lipoprotein — The Clinical Implications of Recent Studies

Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · see citing works

Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities

D, E. B. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,428 · see citing works

Antiinflammatory Properties of HDL

Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394 · see citing works

Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · see citing works

Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics

Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L. D., Pierce, K. G., Mendoza, A. M., Sevinsky, J. R., Resing, K. A., & Ahn, N. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500084-mcp200 · Cited by 1,206 · see citing works

Creating the Gene Ontology Resource: Design and ImplementationPreprint

The Gene Ontology Consortium (2001) · Genome Research · doi:10.1101/gr.180801 · Cited by 957 · see citing works

Creating the gene ontology resource: design and implementation.

Blake, J. A., Corradi, J., Eppig, J. T., Hill, D. P., Richardson, J. E., & Ringwald, M. (2001) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 826 · see citing works

Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database

Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787 · see citing works

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Zheng, L., Nukuna, B. N., Brennan, M., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21109 · Cited by 735 · see citing works

The International Protein Index: An integrated database for proteomics experiments

Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y., Birney, E., & Apweiler, R. (2004) · PROTEOMICS · doi:10.1002/pmic.200300721 · Cited by 693 · see citing works

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

Navab, M., Ananthramaiah, G. M., Reddy, S. T., Lenten, B. J. V., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S. Y., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 687 · see citing works

Targeting C-reactive protein for the treatment of cardiovascular disease.

Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672 · see citing works

High density lipoprotein cholesterol and mortality. The Framingham Heart Study.

Wilson, P. W. F., Abbott, R. D., & Castelli, W. P. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.6.737 · Cited by 644 · see citing works

Molecular regulation of HDL metabolism and function: implications for novel therapies

Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 603 · see citing works

Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity

Barzilai, N. (2003) · JAMA · doi:10.1001/jama.290.15.2030 · Cited by 576 · see citing works

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454 · see citing works

GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies

Zhang, B., Schmoyer, D. D., Kirov, S. A., & Snoddy, J. R. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-16 · Cited by 450 · see citing works

A macro and micro view of coronary vascular insult in ischemic heart disease.

Mj, D. (1990) · PubMed · Cited by 404 · see citing works

Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation

Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & Du, B. N. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338 · see citing works

A Novel Human Apolipoprotein (apoM)

Xu, N., & Dahlbäck, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31286 · Cited by 336 · see citing works

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

Matsuura, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27602 · Cited by 293 · see citing works

Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species

Pennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S. Y., Singh, P., Green, P. S., McDonald, T. O., Brunzell, J. D., Chait, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406762200 · Cited by 263 · see citing works

Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol

Mendez, A. J., Oram, J. F., & Bierman, E. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99196-9 · Cited by 257 · see citing works

Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages

Mak, P. A., Laffitte, B. A., Desrumaux, C. M., Joseph, S. B., Curtiss, L. K., Mangelsdorf, D. J., Tontonoz, P., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202993200 · Cited by 244 · see citing works

Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry

Karlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. G. (2005) · PROTEOMICS · doi:10.1002/pmic.200401010 · Cited by 240 · see citing works

Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

Chait, A., Han, C. Y., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400017-jlr200 · Cited by 230 · see citing works

Inter-α-trypsin Inhibitor, a Covalent Protein-Glycosaminoglycan-Protein Complex

Zhuo, L., Hascall, V., & Kimata, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300039200 · Cited by 229 · see citing works

Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas

Duchateau, P. N., Pullinger, C. R., Orellana, R. E., Kunitake, S. T., Naya-Vigne, J. M., O'Connor, P. M., Malloy, M. J., & Kane, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25576 · Cited by 226 · see citing works

Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

Marcel, Y. L., McPherson, R., Hogue, M., Czarnecka, H., Zawadzki, Z. A., WEECH, P. K., Whitlock, M. E., Tall, A. R., & Milne, R. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114397 · Cited by 215 · see citing works

The Novel Apolipoprotein A5 Is Present in Human Serum, Is Associated with VLDL, HDL, and Chylomicrons, and Circulates at Very Low Concentrations Compared with Other Apolipoproteins

O'Brien, P. J., Alborn, W. E., Sloan, J. H., Ulmer, M., Boodhoo, A., Knierman, M. D., Schultze, A. E., & Konrad, R. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.040824 · Cited by 215 · see citing works

Regulation and mechanisms of macrophage cholesterol efflux

Tall, A. R., Costet, P., & Wang, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16391 · Cited by 213 · see citing works

Investigation of an albumin‐enriched fraction of human serum and its albuminome

Gundry, R. L., Fu, Q., Jelinek, C., Eyk, J. E. V., & Cotter, R. J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200600276 · Cited by 194 · see citing works

Proteomic analysis of high‐density lipoprotein

Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D., & Meijers, J. C. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500191 · Cited by 174 · see citing works

Putting cholesterol in its place: apoE and reverse cholesterol transport

Mahley, R. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28632 · Cited by 173 · see citing works

Paraoxonase, a cardioprotective enzyme: continuing issues

Getz, G. S., & Reardon, C. A. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00005 · Cited by 170 · see citing works

Human High Density Lipoproteins Are Platforms for the Assembly of Multi-component Innate Immune Complexes

Shiflett, A. M., Bishop, J. R., Pahwa, A. K., & Hajduk, S. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503510200 · Cited by 148 · see citing works

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Kunitake, S. T., Jarvis, M. R., Hamilton, R. L., & Kane, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6993 · Cited by 137 · see citing works

Role of complement activation in atherosclerosis

Oksjoki, R., Kovanen, P. T., & Pentikäinen, M. O. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00008 · Cited by 130 · see citing works

Reproducibility of Quantitative Proteomic Analyses of Complex Biological Mixtures by Multidimensional Protein Identification Technology

Washburn, M. P., Ulaszek, R. R., & Yates, J. R. (2003) · Analytical Chemistry · doi:10.1021/ac034120b · Cited by 120 · see citing works

Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein

Shao, B., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231402.87232.aa · Cited by 119 · see citing works

The Role of Complement Activation in Atherosclerosis

Niculescu, F. I., & Rus, H. (2004) · Immunologic Research · doi:10.1385/ir:30:1:073 · Cited by 109 · see citing works

Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

McVicar, J. P., Kunitake, S. T., Hamilton, R. L., & Kane, J. P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1356 · Cited by 106 · see citing works

Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography

Cheung, M. C., Segrest, J. P., Albers, J. J., Cone, J. T., Brouillette, C. G., Chung, B. H., Kashyap, M. L., Glasscock, M. A., & Anantharamaiah, G. M. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38631-4 · Cited by 103 · see citing works

Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9.

Hamilton, K. K., Zhao, J., & Sims, P. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53740-6 · Cited by 102 · see citing works

Proteomics strategies for protein identification

Resing, K. A., & Ahn, N. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.12.001 · Cited by 101 · see citing works

Mass spectrometry‐based analytical tools for the molecular protein characterization of human plasma lipoproteins

Heller, M., Stalder, D., Schlappritzi, E., Hayn, G., Matter, U., & Haeberli, A. (2005) · PROTEOMICS · doi:10.1002/pmic.200401233 · Cited by 83 · see citing works

Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease

Wilson, H. M., Patel, J. C., Russell, D., & SKINNER, E. R. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90046-7 · Cited by 82 · see citing works

High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation

McPherson, P. A. C., Young, I. S., McKibben, B. M., & McEneny, J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600094-jlr200 · Cited by 70 · see citing works

Diverse range of small peptides associated with high-density lipoprotein

Hortin, G. L., Shen, R., Martin, B. M., & Remaley, A. T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.098 · Cited by 63 · see citing works

Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations.

Cheung, M. C., & Wolf, A. C. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38558-8 · Cited by 62 · see citing works

A Dataset of Human Liver Proteins Identified by Protein Profiling Via Isotope-coded Affinity Tag (ICAT) and Tandem Mass Spectrometry

Yan, W., Lee, H., Deutsch, E. W., Lázaro, C. A., Tang, W., Chen, E., Fausto, N., Katze, M. G., & Aebersold, R. H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.d400001-mcp200 · Cited by 61 · see citing works

Identification of Proteins Associated with Apolipoprotein A-I-Containing Lipoproteins Purified by Selected-Affinity Immunosorption

Kunitake, S. T., Carilli, C. T., Lau, K. H., Protter, A. A., Naya-Vigne, J. M., & Kane, J. P. (1994) · Biochemistry · doi:10.1021/bi00174a003 · Cited by 55 · see citing works

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro

Vuletic, S., Peskind, E. R., Marcovina, S. M., Quinn, J. F., Cheung, M. C., Kennedy, H., Kaye, J. A., Jin, L., & Albers, J. J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20458 · Cited by 52 · see citing works

Serpins, the vasculature, and viral therapeutics

Richardson, J. (2006) · Frontiers in bioscience · doi:10.2741/1862 · Cited by 48 · see citing works

Biglycan, a Vascular Proteoglycan, Binds Differently to HDL 2 and HDL 3

Olin, K. L., Potter‐Perigo, S., Barrett, P. H. R., Wight, T. N., & Chait, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.129 · Cited by 45 · see citing works

Unique lipoprotein phenotype and genotype associated with exceptional longevity

Barzilai, N., Atzmon, G., & Schechter, C. B. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.029 · Cited by 41 · see citing works

Expression of Human Apolipoprotein A-I/C-III/A-IV Gene Cluster in Mice Induces Hyperlipidemia but Reduces Atherogenesis

Vergnes, L., Baroukh, N., Ostos, M. A., Castro, G. R., Duverger, N., Nanjee, M. N., Najïb, J., Fruchart, J., Miller, N. E., Zakin, M. M., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2267 · Cited by 33 · see citing works

Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro.

Strunk, R. C., Kunke, K., & Giclas, P. C. (1983) · PubMed · Cited by 33 · see citing works

Deaths: preliminary data for 2003 (USA)

Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · National vital statistics reports · Cited by 30 · see citing works

Human apoC-IV: isolation, characterization, and immunochemical quantification in plasma and plasma lipoproteins

Kotite, L., Zhang, L.-H., Yu, Z., Burlingame, A. L., & Havel, R. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300087-jlr200 · Cited by 25 · see citing works

Fibrinogen is a component of a novel lipoprotein particle: Factor H–related protein (FHRP)–associated lipoprotein particle (FALP)

Park, C. T., & Wright, S. D. (2000) · Blood · doi:10.1182/blood.v95.1.198 · Cited by 23 · see citing works

Virtual two‐dimensional gel electrophoresis of high‐density lipoproteins

Loo, R. R. O., Yam, L. M., Loo, J. A., & Schumaker, V. N. (2004) · Electrophoresis · doi:10.1002/elps.200405955 · Cited by 22 · see citing works

Regulation and mechanisms of macrophage cholesterol efflux

Tall, A. R., Costet, P., & Wang, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216391 · Cited by 20 · see citing works

Identification, Characterization, Cloning, and Expression of Apolipoprotein C-IV, a Novel Sialoglycoprotein of Rabbit Plasma Lipoproteins

Zhang, L., Kotite, L., & Havel, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1776 · Cited by 17 · see citing works

Progress and challenges in translating the biology of atherosclerosis

Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · see citing works

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 3,037 · see citing works

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943 · see citing works

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953 · see citing works

Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis

Tenzer, S., Docter, D., Rosfa, S., Wlodarski, A., Kuharev, J., Rekik, A., Knauer, S. K., Bantz, C., Nawroth, T., Bier, C., et al. (2011) · ACS Nano · doi:10.1021/nn201950e · Cited by 854 · see citing works

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

Navab, M., Reddy, S. T., Lenten, B. J. V., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 656 · see citing works

Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association

Bays, H. E., Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L. J., Brown, W. V., Gonzalez-Campoy, J. M., Jones, S. R., Kumar, R., La Forge, R., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.04.001 · Cited by 521 · see citing works

Translating molecular discoveries into new therapies for atherosclerosis

Rader, D. J., & Daugherty, A. (2008) · Nature · doi:10.1038/nature06796 · Cited by 515 · see citing works

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 511 · see citing works

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T., & Wang, N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.001 · Cited by 540 · see citing works

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471 · see citing works

Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease

Frikke-Schmidt, R. (2008) · JAMA · doi:10.1001/jama.299.21.2524 · Cited by 464 · see citing works

A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation

Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo‐Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442 · see citing works

Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function

Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415 · see citing works

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

Drew, B. G., Duffy, S. J., Formosa, M. F., Natoli, A. K., Henstridge, D. C., Penfold, S. A., Thomas, W. G., Mukhamedova, N., de Courten, B., Forbes, J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843219 · Cited by 443 · see citing works

Inflammation Impairs Reverse Cholesterol Transport In Vivo

McGillicuddy, F. C., Moya, M. D. L. L., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 392 · see citing works

SUBRETINAL DRUSENOID DEPOSITS IN NON-NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Morphology, Prevalence, Topography, and Biogenesis Model

Curcio, C. A., Messinger, J. D., Sloan, K. R., McGwin, G., Medeiros, N. E., & Spaide, R. F. (2013) · Retina · doi:10.1097/iae.0b013e31827e25e0 · Cited by 384 · see citing works

Co‐isolation of extracellular vesicles and high‐density lipoproteins using density gradient ultracentrifugation

Yuana, Y., Levels, J. H. M., Grootemaat, A. E., Sturk, A., & Nieuwland, R. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.23262 · Cited by 380 · see citing works

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

SHAH, A. S., Tan, L., Long, J. L., & Davidson, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r035725 · Cited by 352 · see citing works

High-density lipoproteins: A consensus statement from the National Lipid Association

Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling

Riwanto, M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.108753 · Cited by 337 · see citing works

The emerging role of HDL in glucose metabolism

Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307 · see citing works

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298 · see citing works

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

Kontush, A., & Chapman, M. J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833bcdc1 · Cited by 294 · see citing works

Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities

Ali, K. M., Wonnerth, A., Huber, K., & Wojta, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02081.x · Cited by 296 · see citing works

High-Density Lipoprotein

Lüscher, T. F., Landmesser, U., von Eckardstein, A., & Fogelman, A. M. (2014) · Circulation Research · doi:10.1161/circresaha.114.300935 · Cited by 292 · see citing works

Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins

Curcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.001 · Cited by 286 · see citing works

Structure of HDL: Particle Subclasses and Molecular Components

Kontush, A., Lindahl, M. G., Lhomme, M., Calabresi, L., Chapman, M. J., & Davidson, W. S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_1 · Cited by 284 · see citing works

Cholesterol in the retina: The best is yet to come

Pikuleva, I. A., & Curcio, C. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.03.002 · Cited by 282 · see citing works

HDL cholesterol: reappraisal of its clinical relevance

März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67478 · Cited by 269 · see citing works

Uremia Alters HDL Composition and Function

Holzer, M., Birner‐Gruenberger, R., Stojaković, T., El‐Gamal, D., Binder, V., Wadsack, C., Heinemann, Á., & Marsche, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111144 · Cited by 269 · see citing works

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 257 · see citing works

High-density lipoproteins, reverse cholesterol transport and atherogenesis

Pownall, H. J., Rosales, C., Gillard, B. K., & Gotto, A. M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00538-z · Cited by 250 · see citing works

A new perspective on lipid research in age-related macular degeneration

van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247 · see citing works

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma

Huang, R., Silva, R. A. G. D., Jerome, W. G., Kontush, A., Chapman, M. J., Curtiss, L. K., Hodges, T. J., & Davidson, W. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2028 · Cited by 246 · see citing works

Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future

Good, D. M., Thongboonkerd, V., Novák, J., Bascands, J., Schanstra, J. P., Coon, J. J., Dominiczak, A. F., & Mischak, H. (2007) · Journal of Proteome Research · doi:10.1021/pr070529w · Cited by 244 · see citing works

Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography

Gordon, S. M., Deng, J., Lu, L. J., & Davidson, W. S. (2010) · Journal of Proteome Research · doi:10.1021/pr100520x · Cited by 243 · see citing works

Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib

Yvan‐Charvet, L., Kling, J., Pagler, T. A., Li, H., Hubbard, B. K., Fisher, T., Sparrow, C. P., Taggart, A. K. P., & Tall, A. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207142 · Cited by 238 · see citing works

Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells

Rütti, S., Ehses, J. A., Sibler, R., Prazak, R., Rohrer, L., Georgopoulos, S., Meier, D. T., Niclauß, N., Berney, T., Donath, M. Y., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0252 · Cited by 237 · see citing works

Recent advances in physiological lipoprotein metabolism

Ramasamy, I. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0358 · Cited by 234 · see citing works

High-density lipoproteins during sepsis: from bench to bedside

Tanaka, S., Couret, D., Tran‐Dinh, A., Duranteau, J., Montravers, P., Schwendeman, A. A., & Meilhac, O. (2020) · Critical Care · doi:10.1186/s13054-020-02860-3 · Cited by 230 · see citing works

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk

Harchaoui, K. E., Arsenault, B. J., Franssen, R., Després, J., Hovingh, G. K., Stroes, E. S. G., Otvos, J. D., Wareham, N. J., Kastelein, J. J. P., Khaw, K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00006 · Cited by 228 · see citing works

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk

Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227 · see citing works

Urinary Proteomic Biomarkers in Coronary Artery Disease

Zimmerli, L., Schiffer, E., Zürbig, P., Good, D. M., Kellmann, M., Mouls, L., Pitt, A. R., Coon, J. J., Schmieder, R. E., Peter, K., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700394-mcp200 · Cited by 226 · see citing works

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

Kosmas, C. E., Martinez, I., Sourlas, A., Bouza, K. V., Campos, F. N., Torres, V., Montan, P. D., & Guzman, E. (2018) · Drugs in Context · doi:10.7573/dic.212525 · Cited by 232 · see citing works

Lipid parameters for measuring risk of cardiovascular disease

Arsenault, B. J., Boekholdt, S. M., & Kastelein, J. J. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.223 · Cited by 228 · see citing works

Translation of High-Density Lipoprotein Function Into Clinical Practice

Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P. J., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2013) · Circulation · doi:10.1161/circulationaha.113.000962 · Cited by 224 · see citing works

The role of dysfunctional HDL in atherosclerosis

Navab, M., Reddy, S. T., Lenten, B. J. V., Anantharamaiah, G. M., & Fogelman, A. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800036-jlr200 · Cited by 222 · see citing works

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Vergeer, M., Holleboom, A. G., Kastelein, J. J. P., & Kuivenhoven, J. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001610 · Cited by 220 · see citing works

Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular disease

Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 219 · see citing works

Dysfunctional proinflammatory high‐density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

McMahon, M. A., Grossman, J. M., Skaggs, B. J., FitzGerald, J. D., Sahakian, L., Ragavendra, N., Charles‐Schoeman, C., Watson, K. E., Wong, W. K., Volkmann, E. R., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24677 · Cited by 216 · see citing works

Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics

Ronsein, G. E., Pamir, N., von Haller, P. D., Kim, D. S., Oda, M. N., Jarvik, G. P., Vaisar, T., & Heinecke, J. W. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.10.017 · Cited by 213 · see citing works

The Structure of Apolipoprotein A-I in High Density Lipoproteins

Davidson, W. S., & Thompson, T. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700014200 · Cited by 211 · see citing works

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity

Vaisar, T., Tang, C., Babenko, I. M., Hutchins, P. M., Wimberger, J., Suffredini, A. F., & Heinecke, J. W. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059089 · Cited by 210 · see citing works

Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes

Silva, R. A. G. D., Huang, R., Morris, J. C., Fang, J., Gracheva, E. O., Ren, G., Kontush, A., Jerome, W. G., Rye, K., & Davidson, W. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803626105 · Cited by 206 · see citing works

HDL and endothelial protection

Tran‐Dinh, A., Diallo, D., Delbosc, S., Varela, L. M., Dang, Q., Lapergue, B., Burillo, E., Michel, J., Levoye, A., Martı́n-Ventura, J. L., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12174 · Cited by 205 · see citing works

Multiple actions of high-density lipoprotein

Florentin, M., Liberopoulos, E. N., Wierzbicki, A. S., & Mikhailidis, D. P. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283043806 · Cited by 200 · see citing works

Serum Amyloid A in Uremic HDL Promotes Inflammation

Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070668 · Cited by 201 · see citing works

The HDL proteome in acute coronary syndromes shifts to an inflammatory profile

Al-Waili, K., Bailey, D., Awan, Z. A., Bailey, S. D., Ruel, I. L., Hafiane, A., Krimbou, L., LaBoissière, S., & Genest, J. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.013 · Cited by 200 · see citing works

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

Morgantini, C., Natali, A., Boldrini, B., Imaizumi, S., Navab, M., Fogelman, A. M., Ferrannini, E., & Reddy, S. T. (2011) · Diabetes · doi:10.2337/db11-0378 · Cited by 200 · see citing works

Novel methodologies for biomarker discovery in atherosclerosis

Hoefer, I. E., Steffens, S., Ala‐Korpela, M., Bäck, M., Badimón, L., Bochaton‐Piallat, M., Boulanger, C. M., Caligiuri, G., Dimmeler, S., Egido, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv236 · Cited by 201 · see citing works

Lipid and Lipoprotein Metabolism

Feingold, K. R. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.008 · Cited by 198 · see citing works

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk

Hafiane, A., & Genest, J. J. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.01.005 · Cited by 195 · see citing works

Metabolic and functional relevance of HDL subspecies

Asztalos, B. F., Tani, M., & Schaefer, E. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283468061 · Cited by 192 · see citing works

Emerging role of high density lipoproteins as a player in the immune system

Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 192 · see citing works

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

Sattler, K., Elbasan, Ş., Keul, P., Elter-Schulz, M., Bode, C., Gräler, M. H., Bröcker‐Preuß, M., Budde, T., Erbel, R., Heusch, G., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0112-5 · Cited by 192 · see citing works

Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL function

Millar, C. L., Duclos, Q., & Blesso, C. N. (2017) · Advances in Nutrition · doi:10.3945/an.116.014050 · Cited by 204 · see citing works

Laboratory Assessment of HDL Heterogeneity and Function

Movva, R., & Rader, D. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101923 · Cited by 187 · see citing works

HDL-mediated mechanisms of protection in cardiovascular disease

Kontush, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu147 · Cited by 194 · see citing works

Effects of curcumin on HDL functionality

Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.008 · Cited by 186 · see citing works

Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein

Shao, B., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx9003775 · Cited by 185 · see citing works

High-Density Lipoproteins

Annema, W., & von Eckardstein, A. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1025 · Cited by 182 · see citing works

Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Kunnen, S., & Eck, M. V. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024513 · Cited by 177 · see citing works

New insights into the determination of HDL structure by apolipoproteins

Phillips, M. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r034025 · Cited by 172 · see citing works

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection

Sattler, K., & Levkau, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp070 · Cited by 174 · see citing works

HDL dysfunction in diabetes: causes and possible treatments

Farbstein, D., & Levy, A. P. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.182 · Cited by 174 · see citing works

Psoriasis alters HDL composition and cholesterol efflux capacity

Holzer, M., Wolf, P., Ćurčić, S., Birner‐Gruenberger, R., Weger, W., Inzinger, M., El‐Gamal, D., Wadsack, C., Heinemann, Á., & Marsche, G. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027367 · Cited by 173 · see citing works

HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis

Tsompanidi, E. M., Brinkmeier, M. S., Fotiadou, E. H., Giakoumi, S. M., & Kypreos, K. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.034 · Cited by 169 · see citing works

The HDL proteome: a marker–and perhaps mediator–of coronary artery disease

Heinecke, J. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800097-jlr200 · Cited by 168 · see citing works

Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1α

Sepúlveda, D., Rojas‐Rivera, D., Rodríguez, D. A., Groenendyk, J., Kohler, A., Lebeaupin, C., Ito, S., Urra, H., Carreras‐Sureda, A., Hazari, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.028 · Cited by 163 · see citing works

High-density lipoproteins, inflammation and oxidative stress

Tabet, F., & Rye, K. (2008) · Clinical Science · doi:10.1042/cs20080106 · Cited by 164 · see citing works

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy

Cruz, D., Watson, A. D., Miller, C. S., Montoya, D. J., Ochoa, M. T., Sieling, P. A., Gutierrez, M. A., Navab, M., Reddy, S. T., Witztum, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34189 · Cited by 161 · see citing works

Dysfunctional HDL as a Diagnostic and Therapeutic Target

Smith, J. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179226 · Cited by 157 · see citing works

Anti‐oxidant properties of high‐density lipoprotein and atherosclerosis

Podrez, E. A. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05380.x · Cited by 154 · see citing works

HDL functionality

Soran, H., Hama, S., Yadav, R., & Durrington, P. N. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328355ca25 · Cited by 150 · see citing works

Abnormal function of high‐density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

Charles‐Schoeman, C., Watanabe, J., Lee, Y. Y., Fürst, D. E., Amjadi, S., Elashoff, D. A., Park, G. S. H., McMahon, M. A., Paulus, H. E., Fogelman, A. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24802 · Cited by 150 · see citing works

The Major Yolk Protein Vitellogenin Interferes with the Anti-Plasmodium Response in the Malaria Mosquito Anopheles gambiae

Rono, M. K., Whitten, M. M. A., Oulad‐Abdelghani, M., Levashina, E. A., & Marois, É. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000434 · Cited by 150 · see citing works

The macrophage: the intersection between HIV infection and atherosclerosis

Crowe, S. M., Westhorpe, C. L. V., Mukhamedova, N., Jaworowski, A., Sviridov, D., & Bukrinsky, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809580 · Cited by 148 · see citing works

High-Density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged With Lipopolysaccharide

Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R. E., Vaisar, T., de Beer, M. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961193 · Cited by 143 · see citing works

A Comparison of the Mouse and Human Lipoproteome: Suitability of the Mouse Model for Studies of Human Lipoproteins

Gordon, S. M., Li, H., Zhu, X., SHAH, A. S., Lu, L. J., & Davidson, W. S. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00213 · Cited by 143 · see citing works

Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease

Jensen, M. K., Rimm, E. B., Furtado, J. D., & Sacks, F. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000232 · Cited by 142 · see citing works

Multiple-Reaction Monitoring–Mass Spectrometric Assays Can Accurately Measure the Relative Protein Abundance in Complex Mixtures

Hoofnagle, A. N., Becker, J. O., Oda, M. N., Cavigiolio, G., Mayer, P., & Vaisar, T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173856 · Cited by 140 · see citing works

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

Asleh, R., Blum, S., Kalet-Litman, S., Alshiek, J. A., Miller‐Lotan, R., Asaf, R., Rock, W., Aviram, M., Milman, U., Shapira, C., et al. (2008) · Diabetes · doi:10.2337/db08-0450 · Cited by 139 · see citing works

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

Delles, C., Schiffer, E., Mühlen, C. V. Z., Peter, K., Rossing, P. R., Parving, H., Dymott, J. A., Neisius, U., Zimmerli, L., Snell‐Bergeon, J. K., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833d81b7 · Cited by 138 · see citing works

The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function

Davidson, W. S., SHAH, A. S., Sexmith, H., & Gordon, S. M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159072 · Cited by 138 · see citing works

HDL Remodeling During the Acute Phase Response

Jahangiri, A., de Beer, M. C., Noffsinger, V. P., Tannock, L. R., Ramaiah, C., Webb, N. R., van der Westhuyzen, D. R., & de Beer, F. C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178681 · Cited by 135 · see citing works

High‐density lipoprotein: A potent inhibitor of inflammation

Murphy, A. J., & Woollard, K. J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05338.x · Cited by 139 · see citing works

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

Yetukuri, L., Söderlund, S., Koivuniemi, A., Seppänen‐Laakso, T., Niemelä, P. S., Hyvönen, M., Taskinen, M., Vattulainen, I., Jauhiainen, M., & Orešič, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006494 · Cited by 134 · see citing works

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

Trinder, M., Walley, K. R., Boyd, J. H., & Brunham, L. R. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313381 · Cited by 126 · see citing works

The HDL proteome: a marker–and perhaps mediator–of coronary artery disease

Heinecke, J. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800097-jlr200 · Cited by 168 · see citing works

HDL: More Than Just Cholesterol

Meilina, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i3.123 · Cited by 1 · see citing works

High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis

Gordon, S. M., & Remaley, A. T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.015 · Cited by 70 · see citing works

Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans

Vaisar, T., Shao, B., Green, P. S., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0054-z · Cited by 24 · see citing works

HDL proteomics: pot of gold or Pandora’s box?

Reilly, M. P., & Tall, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31608 · Cited by 38 · see citing works